On April 23, Ge Longhui Pharmaceutical (300006.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 181 million yuan, a year-on-year decrease of 20.09%; net profit attributable to shareholders of listed companies - 4,5753 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 7.4337 million yuan; basic earnings per share - 0.0043 yuan.
莱美药业(300006.SZ)：一季度净亏损457.53万元
Laimei Pharmaceutical (300006.SZ): Net loss of 4.575,300 yuan in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.